Loading clinical trials...
Loading clinical trials...
One-Session Treatment for Specific Phobias in Children
This study will compare the effectiveness of three treatments in reducing symptoms of phobia in children and adolescents.
Children with specific phobias may experience academic, social, and personal distress, as well as interference in day-to-day activities. One-Session Treatment has been found a rapid and effective treatment for adults with phobic disorders. However, its utility in the treatment of childhood phobia has not been examined. Participants are randomly assigned to 1 of 3 groups: a one-session treatment group, an education/support group, and a waitlist control group. The one-session treatment group is directly exposed to a phobia object or situation during a 3-hour treatment session. In the education/support group, children are given information about fear and phobias and are taught how to deal with them through workbook activities. Children who participate in the one-session treatment group or the education/support group are assessed 1 week post-treatment and again after 6 months. Participants with improved symptoms have a 1-year follow-up. Participants with phobias that persist at 6 months are encouraged to participate in alternative treatment. Waitlist control participants are assessed pre-treatment and 1 month post-treatment. Those who continue to have phobias at the 1-month assessment are randomly assigned to 1 of the 2 active treatments.
Age
7 - 16 years
Sex
ALL
Healthy Volunteers
No
VA Polytech. Institute and State University
Blacksburg, Virginia, United States
University of Stockholm
Stockholm, Sweden
Start Date
October 1, 2001
Primary Completion Date
September 1, 2006
Completion Date
September 1, 2006
Last Updated
June 7, 2013
150
ACTUAL participants
One-Session Treatment for Specific Phobias
BEHAVIORAL
Lead Sponsor
Virginia Polytechnic Institute and State University
Collaborators
NCT07432945
NCT06661460
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07235852